1. Home
  2. FGEN vs AWRE Comparison

FGEN vs AWRE Comparison

Compare FGEN & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • AWRE
  • Stock Information
  • Founded
  • FGEN 1993
  • AWRE 1986
  • Country
  • FGEN United States
  • AWRE United States
  • Employees
  • FGEN N/A
  • AWRE N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • FGEN Health Care
  • AWRE Technology
  • Exchange
  • FGEN Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • FGEN 34.5M
  • AWRE 35.2M
  • IPO Year
  • FGEN 2014
  • AWRE 1996
  • Fundamental
  • Price
  • FGEN $0.55
  • AWRE $1.61
  • Analyst Decision
  • FGEN
  • AWRE
  • Analyst Count
  • FGEN 0
  • AWRE 0
  • Target Price
  • FGEN N/A
  • AWRE N/A
  • AVG Volume (30 Days)
  • FGEN 705.5K
  • AWRE 47.3K
  • Earning Date
  • FGEN 02-24-2025
  • AWRE 03-11-2025
  • Dividend Yield
  • FGEN N/A
  • AWRE N/A
  • EPS Growth
  • FGEN N/A
  • AWRE N/A
  • EPS
  • FGEN N/A
  • AWRE N/A
  • Revenue
  • FGEN $180,015,000.00
  • AWRE $16,966,000.00
  • Revenue This Year
  • FGEN $21.91
  • AWRE $10.98
  • Revenue Next Year
  • FGEN N/A
  • AWRE N/A
  • P/E Ratio
  • FGEN N/A
  • AWRE N/A
  • Revenue Growth
  • FGEN 16.15
  • AWRE N/A
  • 52 Week Low
  • FGEN $0.18
  • AWRE $1.35
  • 52 Week High
  • FGEN $2.80
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 58.51
  • AWRE 48.01
  • Support Level
  • FGEN $0.46
  • AWRE $1.54
  • Resistance Level
  • FGEN $0.51
  • AWRE $1.78
  • Average True Range (ATR)
  • FGEN 0.04
  • AWRE 0.12
  • MACD
  • FGEN 0.00
  • AWRE -0.00
  • Stochastic Oscillator
  • FGEN 72.57
  • AWRE 31.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: